Citations 3
P189 Efficacy and safety of upadacitinib maintenance treatment in patients with moderately to severely active crohn’s disease: 3-year results from U-ENDURE
Loftus, Edward V, D’Haens, Geert R, Louis, Edouard, Regueiro, Miguel D, Jairath, Vipul, Magro, Fernando, Nakase, Hiroshi, Dubcenco, Elena, Fish, Irina, Kim, Kimmie, Wang, Y , Anyanwu, Samuel I, Aponte, Fernando, Ogholikhan, Sina, Coll, Christina, Blumenstein, Irina, D’Haens, Geert R, Jairath, Vipul , Magro, F , Nakase, Hiroshi , Anyanwu, Samuel, Ogholikhan, Sina, Blumenstein, Irina
E-Posters | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A198.1-A198
P171 Efficacy and safety of icotrokinra, a targeted oral peptide that blocks il-23 receptor activation, in ulcerative colitis: results from ANTHEM-UC
Limdi, Jimmy, Jairath, Vipul, Siegmund, Britta, Surace, Lindsey, Erondu, Ngozi, Chen, Minhu, Chachu, Karen, Louis, Edouard, Matsuoka, Katsuyoshi, Houck, Nicole, Frustaci, Mary Ellen, Zhan, Joyce, Rydzewska, G, VLoftus, Edward, Abreu, M T, Jairath, Vipul , Siegmund, Britta, Erondu, Ngozi, Chachu, Karen A., Matsuoka, Katsuyoshi , Arthur, Edmund, Frustaci, Mary Ellen, Rydzewska-Wyszkowska, Grażyna
E-Posters | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A188-A188
O60 Icotrokinra, a targeted oral peptide that blocks IL-23 receptor activation, in moderate-to-severe ulcerative colitis: week 12 results from ANTHEM-UC
Limdi, Jimmy, Abreu, M T, Siegmund, Britta, Surace, Lindsey, Erondu, Ngozi, Chen, Minhu, Chachu, Karen, Louis, Edouard, Matsuoka, Katsuyoshi, Houck, Nicole, Frustaci, Mary Ellen, Zou, Bin, Rydzewska, G, Loftus, Edward V, Jairath, Vipul, Siegmund, Britta, Erondu, Ngozi, Chachu, Karen A., Matsuoka, Katsuyoshi , Arthur, Edmund, Frustaci, Mary Ellen, Zou, Bin , Rydzewska-Wyszkowska, Grażyna , Loftus, Edward V , Jairath, Vipul
Oral Abstracts | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A38-A39